Take part in the CANNAVID survey on the impact of COVID-19 on cannabis users
Bus 31/32 and Plus Belle La Nuit (PBLN), in collaboration with INSERM, launch the CANNAVID study on the impact of COVID-19 on the uses, practices and health of regular cannabis users in France.
The main objective of this research is to assess the impact of confinement due to the current coronavirus pandemic on cannabis consumption and consumer health. The questionnaire also looks at the impact of confinement on the experience of the situation, on other use of psychoactive substances and on the strategies put in place for consumption or to cope with a possible shortage.
This research is anonymous. Participants must be daily cannabis users (before confinement), of legal age, resident in France and able to understand French. The questionnaire takes between 15 and 20 minutes to complete.
Le Bus 31/32 is a Marseille-based association that reaches out to drug users. It operates as a CSAPA (Centre de soins, d'accompagnement et de prévention en addictologie) and a CAARUD (Centres d'Accueil et d'Accompagnement à la Réduction de risques pour Usagers de Drogues), and has also set up Plus Belle La Nuit, which is strongly committed to reducing the risks associated with drug use at parties.
The questionnaire is available at this address.
https://www.facebook.com/watch/?v=1553042021521277
-
Business2 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks ago
Which countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164
-
Cannabis in France2 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts


You must be logged in to post a comment Login